180 related articles for article (PubMed ID: 38150734)
1. Pregnancy as an Opportunity for Hepatitis C Virus Elimination and Eradication.
Boudova S; Tholey D; Fenkel JM; Derman R; Boelig RC
Am J Trop Med Hyg; 2024 Feb; 110(2):199-201. PubMed ID: 38150734
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus in Pregnancy: An Opportunity to Test and Treat.
Fogel RS; Chappell CA
Obstet Gynecol Clin North Am; 2023 Jun; 50(2):363-373. PubMed ID: 37149316
[TBL] [Abstract][Full Text] [Related]
3. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.
Wang AE; Hsieh E; Turner BJ; Terrault N
J Gen Intern Med; 2022 Oct; 37(13):3435-3443. PubMed ID: 35484367
[TBL] [Abstract][Full Text] [Related]
4. Planning the hepatitis C virus elimination in Cyprus: A modeling study.
Gountas I; Yiasemi I; Kyprianou E; Mina C; Georgiou C; Katsioloudes P; Kouroufexi A; Demetriou A; Xenofontos E; Nikolopoulos G
World J Gastroenterol; 2021 Aug; 27(31):5219-5231. PubMed ID: 34497446
[TBL] [Abstract][Full Text] [Related]
5. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
[TBL] [Abstract][Full Text] [Related]
6. Cascade of care for children and adolescents with chronic hepatitis C.
Rogers ME; Balistreri WF
World J Gastroenterol; 2021 Mar; 27(12):1117-1131. PubMed ID: 33828389
[TBL] [Abstract][Full Text] [Related]
7. Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
[TBL] [Abstract][Full Text] [Related]
8. [Elimination of hepatitis C virus in Denmark].
Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in children: How do we prevent it and how do we treat it?
Nwaohiri A; Schillie S; Bulterys M; Kourtis AP
Expert Rev Anti Infect Ther; 2018 Sep; 16(9):689-694. PubMed ID: 30091654
[TBL] [Abstract][Full Text] [Related]
10. Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.
McLeod A; Hutchinson SJ; Weir A; Barclay S; Schofield J; Frew CG; Goldberg DJ; Heydtmann M; Wilson-Davies E
Epidemiol Infect; 2022 Jun; 150():e133. PubMed ID: 35757860
[TBL] [Abstract][Full Text] [Related]
11. Postpartum Hepatitis C Linkage to Care Program in a Co-located Substance Use Disorders Treatment Model.
Cheedalla A; Hinely K; Roby L; Hall OT; Malvestutto C; Rood KM
Matern Child Health J; 2023 Dec; 27(Suppl 1):87-93. PubMed ID: 37768533
[TBL] [Abstract][Full Text] [Related]
12. Treating paediatric hepatitis C in the era of direct-acting antiviral agents.
Alqahtani SA; Colombo MG
Liver Int; 2021 Jun; 41(6):1189-1200. PubMed ID: 33533543
[TBL] [Abstract][Full Text] [Related]
13. Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.
van Dijk M; Drenth JPH;
J Viral Hepat; 2020 Dec; 27(12):1270-1283. PubMed ID: 32964615
[TBL] [Abstract][Full Text] [Related]
14. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Infection in Pregnancy and Children: Its Implications and Treatment Considerations with Directly Acting Antivirals: A Review.
Rana R; Dangal R; Singh Y; Gurung RB; Rai B; Sharma AK
JNMA J Nepal Med Assoc; 2021 Sep; 59(241):942-953. PubMed ID: 35199739
[TBL] [Abstract][Full Text] [Related]
16. Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States.
Yee LM; Shah SK; Grobman WA; Labellarte PZ; Barrera L; Jhaveri R
PLoS One; 2022; 17(11):e0277987. PubMed ID: 36399489
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C: Current State of Treatment in Children.
Yadav SR; Goldman DA; Murray KF
Pediatr Clin North Am; 2021 Dec; 68(6):1321-1331. PubMed ID: 34736592
[TBL] [Abstract][Full Text] [Related]
19. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.
McLeod A; Hutchinson SJ; Smith S; Leen C; Clifford S; McAuley A; Wallace LA; Barclay ST; Bramley P; Dillon JF; Fraser A; Gunson RN; Hayes PC; Kennedy N; Peters E; Templeton K; Goldberg DJ
HIV Med; 2021 May; 22(5):334-345. PubMed ID: 33350049
[TBL] [Abstract][Full Text] [Related]
20. Elimination of HCV in Russia: Barriers and Perspective.
Isakov V; Nikityuk D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
